Drugs / A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine
A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00884182 | Apr 2009 → Mar 2010 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00884182 ↗ |
| Modality | Vaccine | “A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine” NCT00884182 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00884182 ↗ |